Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CRI Scientist Receives Russian Federation National Award

    Sergei Nedospasov, PhD, D.Sc., was honored for his contributions to the molecular mediators of immunity, including work…

    July 13, 2016| Alexandra Mulvey
  • Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy

    A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.

    July 6, 2016| Alexandra Mulvey
  • CRI’s Answer to Cancer

    Just after dawn on Saturday, June 25, more than 200 cyclists began to gather in Highland Falls,…

    July 1, 2016| Katherine McCluskey
  • Immunotherapy 101? Ask a Scientist

    As part of Cancer Immunotherapy Month, Dr. Jeffrey Weber answers pressing questions from patients about cancer immunotherapy.

    June 29, 2016| CRI Staff
  • A “White Out” at the NBC TODAY Show Plaza

    On Monday, June 20, the Cancer Research Institute visited the NBC TODAY Show Plaza to raise public…

    June 20, 2016| Katherine McCluskey
  • ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells

    Adoptive T cell therapies provide success against some cancers, hope for several others.

    June 17, 2016| Arthur N. Brodsky, PhD
  • Together, we can #WhiteOutCancer!

    This year we’re on a mission to White Out Cancer—and we need your help!

    June 16, 2016| Katherine McCluskey
  • ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress

    Improved approaches for treating patients with melanoma.

    June 16, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers

    Immunotherapy approaches provide improvements for patients with head and neck cancer.

    June 16, 2016| Arthur N. Brodsky, PhD
Previous Page
1 … 75 76 77 78 79 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal